Measured mg Content
What It Means and Why It Matters

Nominal vs. Measured: The Core Distinction

When a peptide vial is labeled "10mg," that number is almost always a nominal value: the intended fill weight, not a verified measurement of what is actually inside. The nominal label tells you what the manufacturer aimed for. It does not account for fill variability during lyophilization, residual moisture in the powder, or the mass contributed by counterions and excipients that are not active peptide.

At Lone Star Peptide Co., every vial is labeled with the measured mg content: the actual quantity of active peptide determined through analytical testing. This is the number you should use when calculating your working concentration.

Why Nominal and Measured Values Differ

Three factors cause the measured content to differ from the nominal label weight:

1. Residual Water Content

Lyophilized peptides are freeze-dried powders, and even after lyophilization, they retain residual moisture, typically between 5% and 12% of the gross weight. A vial that weighs 10mg on the scale may contain only 8.8–9.5mg of actual peptide once water mass is accounted for. Water content is measured by Karl Fischer titration, a standard analytical method included in our COA panel.

2. Counterion Mass

Peptides are typically supplied as salt forms, most commonly as trifluoroacetate (TFA) or acetate salts, because the salt form is more stable during lyophilization and storage. The counterion contributes mass to the vial but is not the active compound. Depending on the peptide's charge state and the counterion used, this can account for 2–8% of the gross weight.

3. Fill Variability

Even with precise filling equipment, vial-to-vial fill weights vary slightly during the lyophilization process. A batch nominally filled to 10mg per vial may have individual vials ranging from 9.6mg to 10.4mg. Reporting a single nominal value for every vial in a batch obscures this variability.

In this example, a researcher reconstituting the vial in 1mL of sterile water expecting a 10mg/mL solution would actually produce a 9.26mg/mL solution: a 7.4% underestimate. For most preliminary screening work this is acceptable. For dose-response curves, IC50 determinations, or any quantitative assay, this difference is meaningful.

How We Determine Measured mg Content

The measured mg content reported on each Lone Star Peptide Co. vial is derived from the batch Certificate of Analysis (COA), which includes the following analytical tests performed by our independent third-party laboratory:

Net peptide content is calculated as: Gross weight × (HPLC purity − water content % − counterion content %). The result is the mass of active peptide in the vial, which is what we print on the label and document in the COA.

What This Means for Your Reconstitution Calculations

When you reconstitute a peptide, the goal is to achieve a known, reproducible concentration. The standard calculation is:

Concentration (mg/mL) = Measured mg content ÷ Reconstitution volume (mL)

Using the nominal label weight instead of the measured content introduces a systematic error in the direction of underestimating your actual concentration. For most in vitro screening, this is a minor issue. For any experiment where you need to report a precise concentration or where you are comparing results across batches or suppliers, using the measured value is the correct approach.

All Lone Star Peptide Co. COAs include the net peptide content percentage, which allows you to independently verify the measured mg calculation. The COA is included with every order and is searchable in our COA Library by batch number.